Kintara Therapeutics Appoints Tamara A Seymour to Board of Directors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
SAN DIEGO, May 4, 2021
SAN DIEGO, May 4, 2021 /PRNewswire/ Kintara Therapeutics, Inc. (Nasdaq: KTRA) ( Kintara or the Company ), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced the appointment of Tamara A. Seymour to the Company s Board of Directors replacing John Liatos, who will continue in his role as Kintara s Senior Vice President of Business Development. We are delighted to welcome Tamara to the Board of Directors as she brings exceptional healthcare sector experience as an accomplished financial and operational executive, commented Saiid Zarrabian, Kintara s President and Chief Executive Officer. Tamara s insights and perspectives will be a valuable addition to the Board and the entire Company as we continue to advance our platform assets VAL-083 and REM-001. We wish to thank John for his service to the Board and are excited to continue working with him as the Company s Senior VP of Business Development.
Shares of Vital Therapies Inc (NASDAQ: VTL), a biotherapeutic company that focuses on treatment for all forms of acute liver failure, have lost more than 60 percent over the past year, likely prompting Vetr top raters to take advantage of the recent weakness.
Vetr top raters upgraded Vital. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to: